Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis
Links shared publicly online about this topic.
- 454total visits
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis
View full resource at physorg.com
Tags: Skin, Erectile Dysfunction Medication, Neurovascular Disorder, Raynaud Disease, Scleroderma, Viagra
Most Recently Shared on March 12, 2011 at 4:54 pm By:
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis http://tw.physorg.com/218800156
Sildenafil Reduces Raynaud's Frequency In Patients With Systemic Sclerosis
medicalnewstoday.com — “Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sc” View full resource at medicalnewstoday.com
Most Recently Shared on March 9, 2011 at 9:05 am By:
MNT Arthritis News Health News
Sildenafil Reduces Raynaud's Frequency In Patients With Systemic Sclerosis http://mnt.to/3S3H #arthritis
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds
sciencedaily.com — “Researchers in Europe report that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects.” View full resource at sciencedaily.com
Most Recently Shared on March 8, 2011 at 2:51 pm By:
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds http://bit.ly/fgtz5G
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds
sciencedaily.com — “Researchers in Europe report that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects.” View full resource at sciencedaily.com
Most Recently Shared on March 8, 2011 at 2:20 pm By:
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds: Researchers in Europe r... http://bit.ly/eMhWKt
Rheumatology Article | Raynaud Disease Scleroderma, Systemic Sclerosis
mdlinx.com — “Modified-release sildenafil reduces Raynauds phenomenon attack frequency in limited cutaneous systemic sclerosis” View full resource at mdlinx.com
Most Recently Shared on March 2, 2011 at 8:11 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Modified-release sildenafil reduces Raynauds phenomenon attack frequency in limited cutaneous syst... http://bit.ly/g6romO #Rheumatology
Advertisement
